tldrdaily.news logo
Tag

Drug Pipeline

All articles tagged with #drug pipeline

business2 years ago

AbbVie's $8.7 Billion Acquisition of Cerevel Therapeutics: A Game-Changing Deal in Neuroscience

Pharmaceutical company AbbVie has announced its plans to acquire neuroscience drugmaker Cerevel Therapeutics for approximately $8.7 billion. This acquisition is part of AbbVie's strategy to expand its drug pipeline and address the upcoming generic competition for its top-selling treatments. The deal will strengthen AbbVie's portfolio in the field of psychiatric and neurological disorders, bringing in drugs such as Emraclidine, an experimental treatment for schizophrenia and Alzheimer's disease psychosis. AbbVie expects to complete the acquisition in mid-2024.

via CNBC|
#abbvie#acquisition#business
healthcare2 years ago

Roche's $7.1 Billion Telavant Deal Brings Hope for Bowel Disease Treatment

Swiss pharmaceutical company Roche has announced its acquisition of Telavant, an immunology company developing a potential treatment for inflammatory bowel disease, in a deal worth over $7 billion. The deal grants Roche the rights to develop and commercialize Telavant's experimental antibody therapy, RVT-3101, in the United States and Japan. Roche plans to conduct Phase 3 clinical trials for the therapy and collaborate with Pfizer to develop a "next generation" antibody therapy for inflammatory bowel disease. The acquisition aims to strengthen Roche's drug pipeline following several late-stage failures in 2020.

via Forbes|
#drug-pipeline#healthcare#inflammatory-bowel-disease
business2 years ago

Eli Lilly's Drug Pipeline Boosts Profits and Stock Performance

Eli Lilly reported an 85% increase in second-quarter profit, driven by strong sales from its drug pipeline. The pharmaceutical giant raised its full-year revenue guidance to between $33.4 billion and $33.9 billion, up from a previous forecast of $31.2 billion to $31.7 billion. The company also increased its adjusted earnings guidance. Sales growth was fueled by drugs such as Verzenio, Jardiance, and Mounjaro. However, sales of cancer drug Alimta declined due to the expiration of its U.S. patent. Eli Lilly's stock has been performing well, driven by positive trial results for its Alzheimer's drug and progress in its obesity drug pipeline. The company will provide updates on its upcoming pipeline launches and recent acquisitions in a conference call with investors.

via CNBC|
#business#drug-pipeline#earnings
business2 years ago

Moderna's Q1 earnings exceed expectations despite vaccine demand concerns.

Moderna reported a surprise quarterly profit despite lower demand for Covid vaccines, generating $1.9 billion in sales and $79 million in net income for Q1 2022. The company maintained its full-year guidance of around $5 billion in revenue from its Covid vaccine, and is in discussions about new contracts with customers in Europe, Japan, and the US. Moderna is investing aggressively to grow the company by beefing up its mRNA-based drug pipeline, which includes vaccines targeting cancer, heart disease, and other conditions.

via CNBC|
#business#covid-vaccines#drug-pipeline